Lucy Gardner

University of Cambridge

Papers

1

Total Citations

4

H-Index

1

About

Dr. Lucy Gardner is a clinician-researcher whose work centers on improving decision-making in prostate cancer care, with a particular focus on integrating personalized risk-assessment tools into clinical practice. Her major contribution lies in evaluating the real-world utility of decision aids like Predict Prostate, which provide individualized prognostic information to guide treatment choices for patients with intermediate-risk disease. In her landmark 2023 retrospective cohort study—conducted at a specialist tertiary referral centre—Gardner demonstrated how such tools influence both clinician recommendations and patient preferences, empowering shared decision-making and reducing uncertainty around radical treatment. Though early in her career, this work has already garnered attention, accumulating 4 citations and establishing her as a rising voice in urological oncology. Gardner’s research directly addresses a critical gap: translating predictive models from theoretical development into actionable, patient-centered care. Her findings underscore the potential of decision aids to mitigate overtreatment while ensuring that those who need aggressive therapy receive it. For students and researchers, Gardner’s work exemplifies how rigorous clinical evaluation can bridge the gap between data-driven innovation and compassionate, informed practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Utilisation and impact of predict prostate on decision‐making among clinicians and patients in a specialist tertiary referral centre: A retrospective cohort study
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: University of Cambridge

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago